Heart geometry in climacteric syndrome on the background of type 1 diabetes mellitus

Main Article Content

O.A. Goncharova

Abstract

Background. The climacteric period in women with type 1 diabetes mellitus (DM1) initiates an additional damaging effect on the existing cardinal pathology associated with DM. The purpose was to establish the features of geometric remodeling of the left ventricle (LV) of the heart in women with DM1 during the climacteric period. Materials and methods. The study involved 60 women with type 1 diabetes at the age of 48.74 ± 0.65 years, inclu­ding 41 perimenopausal and 19 postmenopausal ones. The control group consisted of 20 women without diabetes mellitus at the age of 50.02 ± 0.71 years. According to echocardiography, taking into account the stage of menopause, the indicators of the end-diastolic volume (EDV) and size (EDS), the posterior wall thickness of the LV (LVPWT) and the interventricular septum (IVST) were analyzed. The frequency of various types of geometric remodeling of the left ventricle of the heart was analyzed using the Penn Convention formula; for this, the LV myocardial mass index (LVMI) was calculated according to the formulas LVMI = 1.04 [(EDS + LVPWT + IVST)3 – EDS3] – 13.6 (LVMI = ratio LVMI to the plane of the body surface (A) in m2; AM2 = 1 + Weight + Δh / 100, where Δh is the difference between the height of a woman and 160 cm) and the relative wall thickness of the LV (LVRWT) LVRWT = 2LVPWT / EDS. Based on these data, the frequency of various types of geometric remodeling was established: normal geometry, concentric remode­ling, concentric or eccentric LV hypertrophy. Results. The data obtained indicate that postmenopausal women present a significant decrease in the frequency of normal heart geometry compared to perimenopausal women (26.4 versus 75.6 %, p < 0.001) and the frequency of concentric LV remodeling 3.5 times increases (26.3 versus 7.3 %, respectively). Concentric hypertrophy and eccentric LV hypertrophy prevailed 2.5 times in postmenopausal women (31.6 versus 12.1 % and 12.7 versus 4.9 %). Conclusions. In perimenopausal women with type 1 diabetes mellitus, in almost a quarter of cases, geometric remodeling of the left ventricle of the heart takes place. In postmenopausal women with estrogen deficiency, the frequency of pathologi­cal forms of heart geometry exceeds 75 %. The strategy of therapy for cardiac pathology in menopausal women against the background of DM1 should take into account the pathogenetic mechanisms of pathology associated with impaired carbohydrate metabolism and atherogenic measurements against the background of estrogen deficiency as well as limit polypharmacy.

Article Details

How to Cite
Goncharova, O. “Heart Geometry in Climacteric Syndrome on the Background of Type 1 Diabetes Mellitus”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 17, no. 4, Sept. 2021, pp. 304-7, doi:10.22141/2224-0721.17.4.2021.237343.
Section
Original Researches

References

Brand JS, Onland-Moret NC, Eijkemans MJ, et al. Diabetes and onset of natural menopause: results from the European Prospective Investigation into Cancer and Nutrition. Hum Reprod. 2015 Jun;30(6):1491-8. doi: 10.1093/humrep/dev054.

Gottschalk MS, Eskild A, Hofvind S, Gran JM, Bjelland EK. Temporal trends in age at menarche and age at menopause: a population study of 312 656 women in Norway. Hum Reprod. 2020 Feb 29;35(2):464-471. doi: 10.1093/humrep/dez288.

Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018 Aug 11;392(10146):477-486. doi: 10.1016/S0140-6736(18)31506-X.

Serhiyenko VO, Serhiyenko OO. Diabetes mellitus and arterial hypertension. Mìžnarodnij endokrinologìčnij žurnal. 2021;17(2):175-188. doi: 10.22141/2224-0721.17.2.2021.230573.

Price MA, Alvarado BE, Rosendaal NTA, Câmara SMA, Pirkle CM, Velez MP. Early and surgical menopause associated with higher Framingham Risk Scores for cardiovascular disease in the Canadian Longitudinal Study on Aging. Menopause. 2021 Jan 4;28(5):484-490. doi: 10.1097/GME.0000000000001729.

Koval SM, Yushko KO, Snihurska IO, et al. Relations of angiotensin-(1-7) with hemodynamic and cardiac structural and functional parameters in patients with hypertension and type 2 diabetes. Arterial Hypertension (Poland) 2019;23(3):183-189. doi: 10.5603/AH.a2019.0012.

Pankiv VI, Yuzvenko TYu, Pankiv IV. Type 2 diabetes mellitus and subclinical hypothyroidism: focusing on the role of cholecalciferol. Problemi endokrinnoi patologii. 2019;(2):46-51. doi: 10.21856/j-PEP.2019.2.07.

Chupin AV, Katorkin SE, Katelnitsky II, et al. Sulodexide in the Treatment of Chronic Venous Insufficiency: Results of the All-Russian Multicenter ACVEDUCT Program. Adv Ther. 2020 May;37(5):2071-2082. doi: 10.1007/s12325-020-01270-9.

Raffetto JD, Calanni F, Mattana P, Khalil RA. Sulodexide promotes arterial relaxation via endothelium-dependent nitric oxide-mediated pathway. Biochem Pharmacol. 2019 Aug;166:347-356. doi: 10.1016/j.bcp.2019.04.021.

Frati Munari AC. Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications. Arch Cardiol Mex. 2014 Apr-Jun;84(2):110-6. (in Spanish). doi: 10.1016/j.acmx.2013.10.006.

Bignamini AA, Chebil A, Gambaro G, Matuška J. Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis. Adv Ther. 2021 Mar;38(3):1483-1513. doi: 10.1007/s12325-021-01620-1.

Liu YN, Zhou J, Li T, et al. Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease. J Diabetes Res. 2017;2017:4989847. doi: 10.1155/2017/4989847.

Most read articles by the same author(s)

1 2 > >>